The primary difference lies in their chemical structure and potency. THC-B has a longer alkyl side chain compared to Delta-9 THC, which may allow it to bind more effectively to CB1 receptors in the brain, potentially making it more potent. Delta-9 THC is more common and widely studied, while THC-B is a rare, recently discovered cannabinoid with limited research available. Both are psychoactive, but THC-B's effects could be stronger or distinct due to its structural differences.

The key difference between CBD and THC-B lies in their psychoactivity and effects. THC-B is psychoactive, potentially more potent than Delta-9 THC, and binds strongly to CB1 receptors, producing euphoria and relaxation. In contrast, CBD is non-psychoactive, offering calming and therapeutic benefits without a "high." While CBD is widely studied and readily available, THC-B is a rare cannabinoid with limited research and accessibility.

THC-B may offer enhanced psychoactive effects compared to Delta-9 THC, including deep relaxation, euphoria, and mood elevation. Its strong interaction with CB1 receptors suggests potential benefits for pain relief, stress reduction, and improved sleep. As a rare cannabinoid, research on THC-B is still limited, but its unique properties make it promising for both recreational and therapeutic applications.